Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy.

Monge, Jorge; Razavi, Meri; Bao, Liming; Patel, Sanjay S

Monge, Jorge; Razavi, Meri; Bao, Liming; Patel, Sanjay S.

Afiliação

Monge J; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College/NewYork-Presbyterian Hospital, New York, New York, USA.
Razavi M; Cytogenetics Laboratory, Weill Cornell Medical College/NewYork-Presbyterian Hospital, New York, New York, USA.
Bao L; Cytogenetics Laboratory, Weill Cornell Medical College/NewYork-Presbyterian Hospital, New York, New York, USA.
Patel SS; Division of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/NewYork-Presbyterian Hospital, New York, New York, USA.

Am J Hematol ; 99(2): 327-328, 2024 Feb.

Article em En | MEDLINE | ID: mdl-37073551

Assuntos

Mieloma Múltiplo; Humanos; Mieloma Múltiplo/tratamento farmacológico; Lenalidomida/efeitos adversos; Talidomida/efeitos adversos; Dexametasona

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google